BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6398078)

  • 1. Dapsone for the treatment of bullous pemphigoid.
    Piamphongsant T
    Asian Pac J Allergy Immunol; 1983 Jun; 1(1):19-21. PubMed ID: 6398078
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone as first line therapy for bullous pemphigoid.
    Venning VA; Millard PR; Wojnarowska F
    Br J Dermatol; 1989 Jan; 120(1):83-92. PubMed ID: 2700666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid in a 3-month-old infant after vaccination.
    Cortés-Pinto C; Baradad Brusau M; Vilardell Vilellas F; Mascaró Galy JM; Arco Huguet N; Soria Gili X
    Clin Exp Dermatol; 2019 Apr; 44(3):341-343. PubMed ID: 30267442
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapsone--other indications.
    Barranco VP
    Int J Dermatol; 1982 Nov; 21(9):513-4. PubMed ID: 6218128
    [No Abstract]   [Full Text] [Related]  

  • 5. Dapsone and sulfapyridine therapy of pemphigoid diseases.
    Rogers RS
    Australas J Dermatol; 1986 Aug; 27(2):58-63. PubMed ID: 3555440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic experience in pemphigus and pemphigoid].
    Aloi FG; Pippione M
    G Ital Dermatol Venereol; 1984; 119(5):357-64. PubMed ID: 6392076
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant therapy of bullous pemphigoid with dapsone.
    Jeffes EW; Ahmed AR
    Clin Exp Dermatol; 1989 Mar; 14(2):132-6. PubMed ID: 2689016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eosinophilic spongiotic pemphigus].
    Aloi FG; Depaoli MA; Bedello PG
    G Ital Dermatol Venereol; 1984; 119(6):381-5. PubMed ID: 6397432
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone.
    Yamane N; Sawamura D; Nishie W; Abe M; Kodama K; Adachi K; Nakamura H; Ishii N; Hashimoto T; Shimizu H
    Br J Dermatol; 2007 May; 156(5):1075-8. PubMed ID: 17381449
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone for the treatment of vesiculo-bullous and pustular diseases.
    Piamphongsant T
    Int J Dermatol; 1982 Nov; 21(9):512. PubMed ID: 6218127
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease.
    Egan CA; Yee C; Zillikens D; Yancey KB
    J Am Acad Dermatol; 2002 May; 46(5):786-9. PubMed ID: 12004326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bullous pemphigoid: diagnostics and new therapeutic strategies].
    Hofmann SC; Bruckner-Tuderman L
    Dtsch Med Wochenschr; 2006 Feb; 131(8):389-92. PubMed ID: 16479471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases.
    Bouscarat F; Chosidow O; Picard-Dahan C; Sakiz V; Crickx B; Prost C; Roujeau JC; Revuz J; Belaich S
    J Am Acad Dermatol; 1996 Apr; 34(4):683-4. PubMed ID: 8601662
    [No Abstract]   [Full Text] [Related]  

  • 14. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
    Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
    Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
    [No Abstract]   [Full Text] [Related]  

  • 16. Bullous pemphigoid and prurigo nodularis.
    Roenigk RK; Dahl MV
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):944-7. PubMed ID: 3519701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous lichen planus: diagnosis by indirect immunofluorescence and treatment with dapsone.
    Camisa C; Neff JC; Rossana C; Barrett JL
    J Am Acad Dermatol; 1986 Mar; 14(3):464-9. PubMed ID: 3514699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the autoimmune pathogenesis of bullous pemphigoid. Review of the literature and our results (author's transl)].
    Haustein UF; Lohrisch I; Herrmann K
    Dermatol Monatsschr; 1980 Sep; 166(9):585-98. PubMed ID: 7004925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autoimmune blistering skin diseases: diagnostic and therapeutic approach].
    Hammers CM; Schmidt E; Zillikens D
    Dtsch Med Wochenschr; 2014 Jul; 139(28-29):1473-7. PubMed ID: 24983196
    [No Abstract]   [Full Text] [Related]  

  • 20. When and how to use sulfones in bullous diseases.
    Jablonska S; Chorzelski T
    Int J Dermatol; 1981 Mar; 20(2):103-5. PubMed ID: 7012048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.